GH Research Statistics
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.53-1.03 (-5.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
GH Research by the numbers
GH Research has a market capitalization of $1.20 billion based on 68.68M shares outstanding. With trailing EPS of $-0.94, GH Research is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.0% below its 50-day average and 19.5% below its 200-day average.
Average daily trading volume is 294.69K shares, or about $5.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GHRS valuation vs. peer median
| Metric | GHRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.20B | $1.22B | -1% |
| Avg. volume | 294.69K | 1.98M | -85% |
Peer median across 8 companies: AMPH, MLYS, OCUL, GENB, SLN, MNKD, OPK, GPCR.
Valuation
- Market cap
- $1.20B
- EPS (TTM)
- $-0.94
- Shares outstanding
- 68.68M
Price and trading
- Previous close
- 18.56
- Open
- 18.32
- Day range
- 17.29 – 18.32
- 52-week range
- 12.04 – 31.44
- 52-week change
- +25.08%
- Beta
- —
- Volume
- 298.83K
- Average volume
- 294.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 1.20B
- Forward Pe
- -10.70
- Eps
- -0.94
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.44
- Week52 Low
- 12.04
- Avg Volume
- 294.69K
- Shares Outstanding
- 68.68M
- Ma50
- 21.37
- Ma200
- 21.77
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -44.24%
- Pct From52w Low
- 45.60%